Scarica l'app Stockscreener
3.38
6.63%
-0.24
Dopo l'orario di chiusura:
3.38
Precedente Chiudi:
$3.62
Aprire:
$3.52
Volume 24 ore:
2,990
Relative Volume:
0.17
Capitalizzazione di mercato:
$470.33M
Reddito:
$16.82M
Utile/perdita netta:
$-112.19M
Rapporto P/E:
-1.5237
EPS:
-2.2183
Flusso di cassa netto:
$-91.84M
1 W Prestazione:
+2.80%
1M Prestazione:
-0.06%
6M Prestazione:
+29.01%
1 anno Prestazione:
-4.79%
Intervallo 1D:
$3.38
$3.6099
Intervallo di 1 settimana:
$3.1339
$3.75
Portata 52W:
$1.53
$4.05
Inventiva Adr Stock (IVA) Company Profile
Confronta IVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
3.38 | 457.28M | 16.82M | -112.19M | -91.84M | -2.2183 |
|
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-21 | Iniziato | TD Cowen | Buy |
| 2024-11-12 | Iniziato | UBS | Neutral |
| 2023-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-31 | Iniziato | ROTH MKM | Buy |
| 2023-05-19 | Aggiornamento | Societe Generale | Sell → Buy |
| 2023-03-17 | Iniziato | Stifel | Buy |
| 2022-11-15 | Downgrade | Societe Generale | Buy → Sell |
| 2021-03-08 | Downgrade | Societe Generale | Buy → Sell |
| 2020-08-05 | Iniziato | ROTH Capital | Buy |
| 2020-08-04 | Iniziato | Guggenheim | Buy |
| 2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Inventiva Adr Borsa (IVA) Ultime notizie
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - sharewise
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference » - GlobeNewswire Inc.
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva
Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com
Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - inventiva.co.in
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Nasdaq
NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - inventiva.co.in
symbol__ Stock Quote Price and Forecast - CNN
Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva
Top 10 Best Handicraft Companies In USA 2023 - inventiva.co.in
Top 20 Best Hardware & Networking Company In India 2023 - inventiva.co.in
Inventiva SaAdr Share Price Today (NASDAQ: IVA)Inventiva SaAdr Stock Price Live Quote - INDmoney
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
Inventiva Adr Azioni (IVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):